Philip Lipari
Pfeiffer Medical Center(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Growth Hormone and Insulin-like Growth Factors, Metabolism, Diabetes, and Cancer, Cancer-related Molecular Pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody(2005)168 cited
- → Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer(1999)109 cited
- → Structure−Activity Relationship of 3-Substituted N-(Pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)- piperidine Inhibitors of Farnesyl-Protein Transferase: Design and Synthesis of in Vivo Active Antitumor Compounds(1997)52 cited
- → Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction(2004)49 cited
- → A Fully Human Insulin-Like Growth Factor-I Receptor Antibody SCH 717454 (Robatumumab) Has Antitumor Activity as a Single Agent and in Combination with Cytotoxics in Pediatric Tumor Xenografts(2010)43 cited
- → Kibdelomycin Is a Potent and Selective Agent against Toxigenic Clostridium difficile(2014)31 cited
- → Inhibitors of Farnesyl Protein Transferase. 4-Amido, 4-Carbamoyl, and 4-Carboxamido Derivatives of 1-(8-Chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-Bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine(1998)28 cited
- → Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models(2023)17 cited
- → Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors(2016)17 cited
- → Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder(2024)10 cited